Obesity-focused biotech BioAge Labs said on Wednesday it was seeking a valuation of as much as $587 million in its initial ...

Obesity drug developer BioAge Labs (BIOA) files for U.S. IPO to offer 7.5M shares at $17-$19 implying valution of up to $602M ...

Obesity-focused biotech BioAge Labs said on Wednesday it was seeking a valuation of as much as $587 million in its initial ...

BioAge Labs, a clinical-stage biotech firm focused on obesity and metabolic disease therapies, aims to raise up to $157.5 million through its initial public offering and private placement, Bloomberg ...

A well-chosen name can carry an idea a long way. That’s especially true in tech, where names become verbs, and the same logic applies to companies, firms, and strategies—and I’d argue Avid Ventures’ ...

ANN ARBOR, Michigan — As vice president, Kamala Harris has been part of an administration that’s poured more than $50 billion into Rust Belt industry and infrastructure. As the Democrats ...

EY Pune employee's death: Shobha Karandlaje was responding to Rajeev Chandrasekhar's post who called the woman's death very sad and “disturbing at many levels”.

Australia's unemployment rate remained at 4.2 per cent in August, as employment grew by 47,500 people.